John Brendan Doyle insider trades

Open-market stock purchases and sales by John Brendan Doyle, Chief Financial Officer at Cognition Therapeutics Inc, from SEC Form 4 filings since Jan 19, 2021.

Recent trades

DateStockTradeValue
May 1, 2026CGTX Cognition Therapeutics IncSold (not open market)$11K
Apr 16, 2026CGTX Cognition Therapeutics IncBought$11.3K
Feb 15, 2026CGTX Cognition Therapeutics IncSold (not open market)$1.7K
Feb 4, 2026CGTX Cognition Therapeutics IncSold (not open market)$27.7K
Feb 3, 2026CGTX Cognition Therapeutics IncBought (not open market)—
Dec 18, 2025CGTX Cognition Therapeutics IncSold (not open market)$14K
Dec 18, 2025CGTX Cognition Therapeutics IncBought (not open market)—

Companies traded

  • CGTX Cognition Therapeutics Inc: 1 buy, last May 1, 2026
  • CHMA Chiasma, Inc: other filings, last Aug 5, 2021

Get free alerts when John Brendan Doyle files a new trade →